Should You Buy Clover Health Stock?

Nicholas Rossolillo, The Motley Fool
·5-min read
Should You Buy Clover Health Stock?

Clover Health Investments (NASDAQ: CLOV) recently made its public debut after merging with one of former Facebook executive Chamath Palihapitiya's SPACs (special purpose acquisition companies). Of the four companies Palihapitiya has targeted so far -- the other three are Virgin Galactic, Opendoor Technologies, and SoFi, soon to merge with SPAC Social Capital Hedosophia Holdings V -- Clover gets me the most excited. Statistics show that most Americans think the healthcare system is "broken".